Related Experiment Video
Updated: Aug 12, 2026
04:30
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis
S D Avakian1, J M Annicchino-Bizzacchi, M Grinberg
1Heart Institute InCor, University of São Paulo Medical School, São Paulo, Brazil.
Clinical Genetics
|March 21, 2002
Summary
Certain apolipoprotein (apo) gene variations, specifically apo B and apo E, are linked to severe aortic valve stenosis (AS). These genetic factors did not correlate with lipid levels or heart measurements in the study.
Area of Science:
- Cardiovascular Genetics
- Lipid Metabolism
- Aortic Valve Disease
Background:
- Hypercholesterolemia is a known risk factor for aortic valve stenosis (AS).
- Apolipoprotein (apo) polymorphisms influence plasma lipid levels, but their direct association with AS remains unclear.
- Understanding genetic predispositions can offer insights into AS pathogenesis.
Purpose of the Study:
- To investigate the association between apolipoprotein AI, B, and E gene polymorphisms and the risk of severe aortic valve stenosis (AS).
- To determine if specific apo polymorphisms correlate with lipid profiles, left ventricular mass, or aortic gradient in AS patients.
Main Methods:
- A case-control study comparing 62 non-diabetic patients with severe AS to 62 matched controls.
- Analysis of apo AI A/G mutation, apo B signal peptide insertion/deletion, apo B XbaI restriction fragment length, and apo E polymorphisms.
- Echocardiographic assessment of all participants.
Main Results:
- A significantly higher prevalence of the apo B XbaI X+/X+ genotype was observed in patients with severe AS (p = 0.007).
- The apo E2 allele was also more frequent in the severe AS group (p = 0.034).
- No significant association was found between apo polymorphisms and lipid levels, left ventricular mass, or aortic gradient.
Conclusions:
- Specific genetic variations in apolipoprotein B and E may be associated with an increased risk of developing severe aortic valve stenosis.
- These apo polymorphisms do not appear to influence lipid levels, cardiac structure, or hemodynamic parameters in the studied population.
- Further research is warranted to elucidate the role of these genetic factors in AS etiology.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:15Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...